These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 39196840)

  • 1. Neurotoxins and Combination Therapies.
    Gawey L; Saedi N; Hausauer A
    Dermatol Surg; 2024 Sep; 50(9S):S85-S90. PubMed ID: 39196840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally Invasive Facial Cosmetic Procedures.
    Devgan L; Singh P; Durairaj K
    Otolaryngol Clin North Am; 2019 Jun; 52(3):443-459. PubMed ID: 30954270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic approaches for the treatment of facial aging].
    Gauglitz GG; Podda M
    Hautarzt; 2015 Oct; 66(10):738-43. PubMed ID: 26349682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Comprehensive, Minimally Invasive, Multimodal Aesthetic Treatment on Satisfaction With Facial Appearance: The HARMONY Study.
    Weinkle SH; Werschler WP; Teller CF; Sykes JM; Shamban A; Rivkin A; Narurkar VA; Kaminer MS; Dayan S; Cohen JL; Gallagher CJ
    Aesthet Surg J; 2018 Apr; 38(5):540-556. PubMed ID: 29244069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Providing Optimal Rejuvenation to the Periocular Area Using Botulinum Toxin A Neuromodulators and Hyaluronic Acid Dermal Fillers.
    Varga R
    Plast Surg Nurs; 2019; 39(4):119-124. PubMed ID: 31790040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical skin therapies in subjects undergoing full facial rejuvenation.
    Dayan SH; Bacos JT; Ho TT; Gandhi ND; Gutierrez-Borst S; Kalbag A
    J Cosmet Dermatol; 2019 Jun; 18(3):798-805. PubMed ID: 31033162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Uses of AbobotulinumtoxinA in Aesthetics.
    Schlessinger J; Gilbert E; Cohen JL; Kaufman J
    Aesthet Surg J; 2017 May; 37(suppl_1):S45-S58. PubMed ID: 28388720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler.
    Cartier H; Hedén P; Delmar H; Bergentz P; Skoglund C; Edwartz C; Norberg M; Kestemont P
    Dermatol Surg; 2020 Apr; 46(4):475-482. PubMed ID: 31592825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periorbital Rejuvenation: Overview of Nonsurgical Treatment Options.
    Glaser DA; Kurta A
    Facial Plast Surg Clin North Am; 2016 May; 24(2):145-52. PubMed ID: 27105800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.
    Sundaram H; Liew S; Signorini M; Vieira Braz A; Fagien S; Swift A; De Boulle KL; Raspaldo H; Trindade de Almeida AR; Monheit G;
    Plast Reconstr Surg; 2016 May; 137(5):1410-1423. PubMed ID: 27119917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J; Carruthers A; Monheit GD; Davis PG
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices.
    Carruthers J; Burgess C; Day D; Fabi SG; Goldie K; Kerscher M; Nikolis A; Pavicic T; Rho NK; Rzany B; Sattler G; Sattler S; Seo K; Werschler WP; Carruthers A
    Dermatol Surg; 2016 May; 42(5):586-97. PubMed ID: 27100962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations.
    Carruthers JDA; Glogau RG; Blitzer A;
    Plast Reconstr Surg; 2008 May; 121(5 Suppl):5S-30S. PubMed ID: 18449026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention Rates Among Patients Undergoing Multimodal Facial Rejuvenation Treatment Versus a Single Monotherapy in Cosmetic Dermatology Practices.
    Gregory A; Humphrey S; Chunharas C; Ogilvie P; Fabi SG
    Dermatol Surg; 2020 Feb; 46(2):240-246. PubMed ID: 31453910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximizing Panfacial Aesthetic Outcomes: Findings and Recommendations From the HARMONY Study.
    Kaminer MS; Cohen JL; Shamban A; Werschler WP; Shumate GT; Drinkwater A; Gallagher CJ
    Dermatol Surg; 2020 Jun; 46(6):810-817. PubMed ID: 31834076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective and Safe Repeated Full-Face Treatments With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin Boosting Hyaluronic Acid.
    Hedén P; Hexsel D; Cartier H; Bergentz P; Delmar H; Camozzato F; Siega C; Skoglund C; Edwartz C; Norberg M; Kestemont P
    J Drugs Dermatol; 2019 Jul; 18(7):682-689. PubMed ID: 31334927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant Use of Hyaluronic Acid and Laser in Facial Rejuvenation.
    Urdiales-Gálvez F; Martín-Sánchez S; Maíz-Jiménez M; Castellano-Miralla A; Lionetti-Leone L
    Aesthetic Plast Surg; 2019 Aug; 43(4):1061-1070. PubMed ID: 31073742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on botulinum toxin and dermal fillers.
    Berbos ZJ; Lipham WJ
    Curr Opin Ophthalmol; 2010 Sep; 21(5):387-95. PubMed ID: 20703120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.